An implant for sleep apnea is one of the few CPAP alternatives. This article compares hypoglossal nerve stimulation and ...

Inspire Medical Systems (NYSE:INSP), known for its innovative devices that use neurostimulation to treat sleep apnea, ...

Inspire Medical Systems (NYSE:INSP) shares rose slightly after hours today on fourth-quarter results that beat the consensus ...

Inspire expects full-year earnings to be $2.10 to $2.20 per share, with revenue in the range of $940 million to $955 million. This story was generated by Automated Insights ( ...

Inspire (INSP) delivered earnings and revenue surprises of 55.41% and 0.04%, respectively, for the quarter ended December 2024. Do the numbers hold clues to what lies ahead for the stock?

The global sleep software market valued at US$ 776.2 Million in 2023, is forecasted to grow at a robust CAGR of 10.1%, reaching US$ 878.9 Million in 2024 and an impressive US$ 1,5 ...

Medical technology company Inspire Medical Systems (NYSE:INSP) reported Q4 CY2024 results topping the market’s revenue ...

Learn more about whether Inspire Medical Systems, Inc. or Teleflex Incorporated is a better investment based on AAII's A+ Investor grades, which compare both companies' key financial metrics.

For treatment resistant cases a surgical device called Inspire (hypoglossal nerve surgery ... Researchers have been on the hunt for new ways to treat sleep apnea and prevent its complications.

Obstructive Sleep Apnea affects 1 in 15 Americans, likely more, and treatment has often involved inconvenient treatments like CPAP machines. A new device called Inspire offers new alternatives for ...

Sleep apnea is a disorder that causes people to ... suggested a different way to treat her apnea. He recommended the Inspire device, which is implanted near a person's collarbone and keeps their ...

Awareness of sleep apnea and its relatively common and ... to the throat muscles to keep the airway clear. Marketed as Inspire, the device is similar to an implanted pacemaker with a handheld ...